Literature DB >> 2056058

Quantification and assessment of viability of Pneumocystis carinii organisms by flow cytometry.

S E Lapinsky1, D Glencross, N G Car, J M Kallenbach, S Zwi.   

Abstract

Analysis of drug efficacy in animal models of Pneumocystis carinii pneumonia requires an accurate method of quantification of organisms, as well as a means of assessing viability. Lung homogenates were prepared from a colony of athymic nude F344 rats experiencing a spontaneous outbreak of P. carinii pneumonia. With the fluorescent nucleic acid stain propidium iodide, flow cytometric analysis was able to quantify P. carinii cysts and trophozoites reproducibly. As this stain is excluded by living cells, this method was also used to assess the viability of organisms. Application of this technique to analysis of bronchoalveolar lavage specimens was demonstrated.

Entities:  

Mesh:

Year:  1991        PMID: 2056058      PMCID: PMC269907          DOI: 10.1128/jcm.29.5.911-915.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Diagnosis of Pneumocystis carinii pneumonia.

Authors:  P D Walzer
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Persistence of pneumocystis.

Authors:  W T Hughes
Journal:  Chest       Date:  1985-07       Impact factor: 9.410

4.  Antimicrobial susceptibility of Pneumocystis carinii in culture.

Authors:  M S Bartlett; R Eichholtz; J W Smith
Journal:  Diagn Microbiol Infect Dis       Date:  1985-09       Impact factor: 2.803

5.  Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; R D Powell; K Yoneda; M E Rutledge; J E Milder
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

6.  Growth and metabolism of Pneumocystis carinii in axenic culture.

Authors:  M T Cushion; D Ebbets
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture.

Authors:  L L Pifer; D D Pifer; D R Woods
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

8.  Growth and serial passage of Pneumocystis carinii in the A549 cell line.

Authors:  M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia.

Authors:  C K Kim; J M Foy; M T Cushion; D Stanforth; M J Linke; H L Hendrix; P D Walzer
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

10.  Analysis of Pneumocystis carinii cysts with a fluorescence-activated cell sorter.

Authors:  C R Libertin; G E Woloschak; W R Wilson; T F Smith
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

View more
  9 in total

Review 1.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 2.  Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses.

Authors:  H M Davey; D B Kell
Journal:  Microbiol Rev       Date:  1996-12

Review 3.  Imaging flow cytometry analysis of intracellular pathogens.

Authors:  Viraga Haridas; Shahin Ranjbar; Ivan A Vorobjev; Anne E Goldfeld; Natasha S Barteneva
Journal:  Methods       Date:  2016-09-15       Impact factor: 3.608

4.  Fractionation of Pneumocystis carinii developmental stages by counterflow centrifugal elutriation and sequential filtrations.

Authors:  J A De Stefano; J M Foy; D W Sullivan; S M Dawes; M T Cushion; G F Babcock; R G Sleight; H van Halbeek; P D Walzer
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

5.  A new method for the detection of Pneumocystis jirovecii using flow cytometry.

Authors:  J Barbosa; C Bragada; S Costa-de-Oliveira; E Ricardo; A G Rodrigues; C Pina-Vaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-16       Impact factor: 3.267

Review 6.  Applications of flow cytometry to clinical microbiology.

Authors:  A Alvarez-Barrientos; J Arroyo; R Cantón; C Nombela; M Sánchez-Pérez
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Microculture screening assay for primary in vitro evaluation of drugs against Pneumocystis carinii.

Authors:  J C Comley; R J Mullin; L A Wolfe; M H Hanlon; R Ferone
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

8.  Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats.

Authors:  F Chen; M T Cushion
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

9.  SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.

Authors:  Annie Standaert-Vitse; Cécile-Marie Aliouat-Denis; Anna Martinez; Sara Khalife; Muriel Pottier; Nausicaa Gantois; Eduardo Dei-Cas; El Moukhtar Aliouat
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.